Parkwalk News

15 March 2019

Oxford PV – raises £31m funding

By |March 15th, 2019|

Perovskite solar technology leader announces first close of Series D funding round, attracting major new investment and continued support from existing shareholders
Oxford PVTM – The Perovskite CompanyTM, the leader in the field of perovskite solar cells, today announced it has raised £31 Million, the first portion of its Series D funding round.
The round includes a […]

Phasecraft – Parkwalk investment

By |March 13th, 2019|

Parkwalk are delighted to welcome Phasecraft to its portfolio following an investment from the Parkwalk Opportunities EIS Fund.

Phasecraft is a start-up from researchers at University College London and the University of Bristol. The company was established to develop quantum software for quantum information processors, encompassing both near-term intermediate-scale devices and universal fault-tolerant quantum computers.

Small-scale […]

Paragraf – starts producing graphene at commercial scale

By |March 12th, 2019|

The University of Cambridge has reported that Paragraf, one of its spinouts and a Parkwalk portfolio company, has started producing graphene

A sheet of carbon just one atomic layer thick, at up to eight inches (20cm) in diameter, large enough for commercial electronic devices.

Professor Sir Colin Humphreys, the founding professor of the technology, is quoted […]

Animal Dynamics – Successful Exit

By |March 12th, 2019|

Parkwalk, the leading EIS investor in UK University spin-out companies, is pleased to announce the exit of the majority of its holding in Animal Dynamics via a successful secondary sale.

Parkwalk was one of the initial investors in the company when it was formed in 2015 and has invested in subsequent funding rounds. The sale […]

PredictImmune – announce formal entry of PredictSURE IBD™ into the NICE Diagnostic Assessment Programme

By |March 12th, 2019|

PredictImmune, developers of pioneering prognostic tools for guiding treatment options and improving patient outcomes in immune-mediated diseases, today announced the formal entry of its first product, PredictSURE IBD™, into NICE’s Diagnostic Assessment Programme (DAP).

The DAP evaluates new, cutting-edge medical diagnostic technologies, producing guidance to help people working in the NHS make efficient, cost-effective and […]

25 February 2019

Petmedix – Parkwalk’s latest investment

By |February 25th, 2019|

Parkwalk are delighted to announces its investment in Petmedix. The Cambridge based pet therapeutics company raises £8M Series A funding, with Parkwalk co-investing alongside Digitalis Ventures. Parkwalk were attracted by the team and the market potential.

PetMedix is applying 30 years of antibody research and the scientific work of two of its founders, Professor Allan Bradley […]

Parkwalk wins ‘Best EIS Fund Manager’ at the EIS Association Awards

By |February 8th, 2019|

Parkwalk are delighted to have won ‘Best EIS Fund Manager’ for 2018 at the annual EIS Association Awards. This is the 3rd year in a row that we have won this prodigious award.

The judges commented that Parkwalk were ‘An impressive manager with a strong track record and regular exits. Exactly what the regulator is looking for […]

30 January 2019

Ilika – Goliath Deployment Project led by McLaren

By |January 30th, 2019|

Ilika announces it has commenced the MoSESS project led by McLaren Automotive to develop its Stereaxâ Goliath batteries to power high-performance vehicles.

The project objective is to develop and integrate into a vehicle a fast-charging and high-power battery system based on advanced cell technology from Ilika and A123 Systems. It will deliver a simpler cooling system […]

Is Venture Capital about to become more of a mainstream asset class?

By |January 29th, 2019|

These are exciting times for the venture capital industry but only if the regulatory authorities back the government and are bold and ambitious in backing growth business.

A changing VC landscape

A few years back, I wrote an article for Tech City News congratulating the government on various initiatives to stimulate an entrepreneurial culture but bemoaning […]

Parkwalk – 2018 in numbers

By |January 15th, 2019|

Parkwalk’s EIS Investment Strategy in relation to Bristol and the UK’s Industrial Strategy

By |January 14th, 2019|

Ahead of the launch of the third University of Bristol Enterprise Fund later this month we take a look at a recent speech given by Business Secretary Greg Clark in Bristol on the first anniversary of the modern Industrial Strategy.

The Bristol launch event is on 29th January 2019 at Brown Rudnick LLP, 8 Clifford […]

Flusso – Opportunities and UCEF V & VI investment

By |January 10th, 2019|

We are delighted to announce that the Parkwalk Opportunities Fund and the University of Cambridge Enterprise Funds V and VI, managed by Parkwalk, have participated in the first major financing round of Flusso, the University of Cambridge spin-out which has developed an innovative high-performance gas flow sensor.

Flusso is a 2018 spin-out from the High […]

GeoSpock Secures £10 Million Additional Funding

By |January 8th, 2019|

GeoSpock® – the extreme-scale data integration company that provides analytics, builds insight, and enables predictions across space and time – today announced it has raised £10 million in additional funding, bringing the total raised to date to £19.25 million.

Investment was led by existing backers Cambridge Innovation Capital (CIC) jointly with Parkwalk Advisors and Japanese firms Global Brain […]

YASA – The World’s Fastest Electric Powered Aeroplane

By |January 2nd, 2019|

This zero-emissions plane is expected to make a run for the record books with a target speed of 300+ MPH (480+ KMH).
Rolls-Royce is leading a highly specialised challenge to build the world’s fastest all-electric aircraft.

Inside a bustling hangar bay at the far end of Gloucestershire airport in South West England, a team of British […]

Cytora and QBE expand its relationship to enhance data-driven business insurance

By |January 2nd, 2019|

Following a successful pilot project, QBE has begun using Cytora’s Risk Engine technology to enhance underwriting decisions across its commercial portfolio.
The Cytora Risk Engine learns the patterns of good and bad risks over time, combining the digital footprint of every business with insurers’ internal data to generate a comprehensive risk profile and score for […]

12 December 2018

Istesso – Parkwalk investment

By |December 12th, 2018|

Parkwalk are delighted to welcome Istesso to its portfolio following an investment from the Parkwalk Opportunities EIS Fund.

Istesso is a drug development company working in the field of immunometabolism. It’s pre-clinical and clinical assets work by reprogramming cellular metabolism and have applications in autoimmune conditions. Istesso’s lead drug, MBS2320, is in a Phase 2a […]

MedaPhor – Parkwalk investment

By |December 11th, 2018|

We are delighted to announce that the Parkwalk Opportunities Fund has  participated in the recent financing round of Medaphor Group plc, the Cardiff University Spin-out and global provider of advanced ultrasound training simulators and ultrasound clinical support for medical professionals.

GOV.UK: Oxford Photovoltaics: a shining light in solar cell innovation

By |December 7th, 2018|

Oxford Photovoltaics: a shining light in solar cell innovation

Early support from Innovate UK kick-started Oxford University spin-out which has set a world record for converting sunlight into power.

Dr Chris Case and Professor Henry Snaith of Oxford Photovoltaics

An Oxfordshire company backed by early financial support from Innovate UK is developing next-generation solar cell technology for […]

Brainomix partners with Oxford University in UK Government funded £17.5 million AI Programme

By |December 7th, 2018|

Brainomix, an Oxford-based world leader in medical imaging software, is teaming up with the University of Oxford to become one of its technology providers for a £17.5m UK government funded project. Brainomix will demonstrate the significant health economic benefits of its AI-based proprietary imaging software solution, e-Stroke Suite, which is already used in routine clinical practice at […]

Ceres Power and Weichai finalise strategic collaboration and JV Agreement

By |December 4th, 2018|

Ceres Power (AIM: CWR, “Ceres”), a world-leading, low cost Solid Oxide Fuel Cell company, and Weichai Power (“Weichai”), one of the leading automobile and equipment manufacturing companies in China, are pleased to announce the finalisation of their long-term strategic collaboration first announced in May 2018. This includes a Joint Venture Agreement with the commitment […]